-
Introducing OurMembersGlobal experts in theresearch, developmentand manufacture ofmedicines.
Pharmaceutical scientists involved with APS

Who We Are
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.
We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
Pharmaceutical Scientists are experts in the research, development and manufacture of medicines. They have a major role in the regulation of medicines and understanding their use in patients.

What We Do
The APS is a not-for-profit organisation. We use revenues to champion innovation and opportunity in Pharmaceutical Sciences thereby improving the development and delivery of medicines for the benefit of patients. Our four key strategic themes, which are the foundation of all APS activities, are:
- Establish and promote the reputation of Pharmaceutical Sciences and Scientists
- Influence policy
- Further scientific knowledge
- Promote careers
Board Roles & Responsibilities
Each member on the board and advisory board is
responsible for a specific area of development
Board Meetings 2021- 21st January, 18th March, 29th April, 17th June, 9th September & 18th November.
Education- John Wahlich
Events- Carol O’Connor
Finance – Geoff Davison
Focus Groups- Julie Cahill & Bob Clay
vPharmSci 2021-Fran Greco, Mark McAllister & Hannah Bachelor
Sponsorship- Linda Hakes, Begona Delgado-Charro
Student & Academic liaison- Vacant
Marketing- Carol O’Connor
Membership – Jo Craig, Gary Parsons and Trish Sharp
Social Media – Hannah Bachelor
Strategy – Mark McAllister, Julie Cahill
Website – Carol O’Connor
2000-1 Graham Buckden
2001-2 Howard Stevens
2002-3 Chris Doherty
2003-5 Tommy Dolan
2005-7 Ijeoma Uchegbu
2007-9 David Wyatt
2008-10 Eddie French
2010-12 Martin Snowden
2012-15 Bill Dawson
2015-17 Linda Hakes
2017-20 Mark McAllister
2020- Jo Craig
APS Priorities for 2021
- Promote and enhance diversity across our membership, board and fellows
- Enhance and communicate the value of APS membership
- Deliver a successful PharmSci 2021 virtual conference Autumn event for our members
- Deliver multiple webinars through 2021 for our members to include repeat of our successful develop ability training event and virtual Industrial Insights for students
- Provide a vibrant Focus Group community for our members, with new groups aligned with current scientific areas
- Support and grow our accredited institution community

The APS Board
The APS Board








Hannah is a pharmaceutical scientist who has worked in academia, the NHS and within pharmaceutical industry. Her research interests lie in the optimisation of drug formulations to maximise their biopharmaceutical performance and acceptability to children. Her research is informed by the views of children, young people and parents to ensure that the patients are at the centre of new developments.
She has been invited to present at many National and International scientific meetings as well as a TED talk.


Dr Delgado-Charro research focuses on transdermal and topical drug delivery, the development of optimized methods to treat and prevent nail diseases, non-invasive sampling for drug monitoring and pharmacokinetics, and the assessment of topical bioavailability and bioequivalence. Her work has been funded by several private and public sponsors and her scholastic work (Scopus author ID: 7003434711) includes 105 peer-reviewed scientific articles, 10 book chapters, and several patent applications. Her academic work focuses on the areas of pharmacokinetics and pharmaceutics in the frame of Pharmacy and Pharmacology degrees.


Prior to her current position as Lecturer in Pharmaceutics at King’s College London, Dr. Raimi-Abraham held positions at University College London (UCL) as an Engineering and Physical Sciences Research Council (EPSRC) postdoctoral researcher position and at the European Medicines Agency (EMA) as a seconded Quality National Expert.
Dr. Raimi-Abraham is the first graduate of the University of East Anglia School of Pharmacy to be awarded a Ph.D. and more recently won the Outstanding Woman in STEM Precious Award.
Dr Raimi-Abraham has an extensive and original public engagement portfolio which includes uniquely exploring the use of street art to engage public with Science, Technology, Engineering and Mathematics (STEM) research through her social enterprise STEAM:ED Collective, a TEDx talk (TEDx Talk title “Elements of Change: Becoming an Independent Researcher) and a “Go and No-go pills” Somerset House 24/7 exhibition, visited by ~35,000 people (Oct. 2019 – Feb. 2020)). More recently hosting a weekly podcast, Monday Science which discusses the latest in Science, Health and Technology. Dr Raimi-Abraham’s work in research informed teaching has also been recognised by the Nuffield Foundation.






Bob is a pharmacist with more than 30 years’ experience in drug development, leading the global regulatory approval of many products across a range of therapy areas including metabolic diseases, neuroscience, cancer, and infection, involving more than 15 new substances. Earlier in his career, he was a formulation scientist and pharmaceutical reviewer at UK regulatory agency. Bob has held significant leadership roles in regulatory affairs in regional and global functions at several companies including AstraZeneca and Pfizer and served as Chief Regulatory Officer at Kinapse (2014-2017).



The Advisory Board
The Advisory Board


Linda is a Vice President of FIP (International Pharmaceutical Federation), a member of the Assembly of Royal Pharmaceutical Society (RPS) and the immediate past Chairman of the Academy of Pharmaceutical Sciences. She is also visiting Professor at Sunderland University and is eligible to be a Qualified Person. Linda is a Fellow of both the Royal Pharmaceutical Society and FIP.


He holds honorary degrees and Gold Medals from 7 universities; is a founder member of Medicines for Malaria Venture (MMV); member of The UK Government Regulatory Agency, The Medicines Commission; advisor to the Cabinet Office on the Human Genome project; Chair of the UK Government Advisory Group on Genetics Research; member of the Wales Government Bevan Commission on health; advised the Government of the Netherlands TiPharma on Life Science and is a member of the EU Commission IMI Scientific Advisory Board.


As a member of the Advisory Board Mike supports the board in developing strategies that promote the pharmaceutical sciences and encourage high standards of practice.











